These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20727744)

  • 1. Azole derivatives as histamine H3 receptor antagonists, part 2: C-C and C-S coupled heterocycles.
    Walter M; Isensee K; Kottke T; Ligneau X; Camelin JC; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5883-6. PubMed ID: 20727744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azole derivatives as histamine H3 receptor antagonists, part I: thiazol-2-yl ethers.
    Walter M; von Coburg Y; Isensee K; Sander K; Ligneau X; Camelin JC; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5879-82. PubMed ID: 20728354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.
    Swanson DM; Shah CR; Lord B; Morton K; Dvorak LK; Mazur C; Apodaca R; Xiao W; Boggs JD; Feinstein M; Wilson SJ; Barbier AJ; Bonaventure P; Lovenberg TW; Carruthers NI
    Eur J Med Chem; 2009 Nov; 44(11):4413-25. PubMed ID: 19577344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationship (SAR) study of 4-azabenzoxazole analogues as H3 antagonists.
    Shao N; Aslanian R; West RE; Williams SM; Wu RL; Hwa J; Sondey C; Lachowicz J; Palani A
    Bioorg Med Chem Lett; 2012 Mar; 22(5):2075-8. PubMed ID: 22326166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New 1-benzyl-4-hydroxypiperidine derivatives as non-imidazole histamine H3 receptor antagonists.
    Maslowska-Lipowicz I; Figlus M; Zuiderveld OP; Walczynski K
    Arch Pharm (Weinheim); 2008 Dec; 341(12):762-73. PubMed ID: 19009544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a new class of non-imidazole oxazoline-based histamine H(3) receptor (H(3)R) inverse agonists.
    Célanire S; Wijtmans M; Christophe B; Collart P; de Esch I; Dassesse D; Delaunoy C; Denonne F; Durieu V; Gelens E; Gillard M; Lallemand B; Lamberty Y; Lebon F; Nicolas JM; Quéré L; Snip E; Vanbellinghen A; Van Houtvin N; Verbois V; Timmerman H; Talaga P; Leurs R; Provins L
    ChemMedChem; 2009 Jul; 4(7):1063-8. PubMed ID: 19405064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-acting drugs: an in vitro study of nonimidazole histamine H3 receptor antagonists combining anticholinesterase activity.
    Incerti M; Flammini L; Saccani F; Morini G; Comini M; Coruzzi M; Barocelli E; Ballabeni V; Bertoni S
    ChemMedChem; 2010 Jul; 5(7):1143-9. PubMed ID: 20512794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorinated non-imidazole histamine H3 receptor antagonists.
    Isensee K; Amon M; Garlapati A; Ligneau X; Camelin JC; Capet M; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2172-5. PubMed ID: 19286376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery of the benzazepine class of histamine H3 receptor antagonists.
    Wilson DM; Apps J; Bailey N; Bamford MJ; Beresford IJ; Briggs MA; Calver AR; Crook B; Davis RP; Davis S; Dean DK; Harris L; Heightman TD; Panchal T; Parr CA; Quashie N; Steadman JG; Schogger J; Sehmi SS; Stean TO; Takle AK; Trail BK; White T; Witherington J; Worby A; Medhurst AD
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6897-901. PubMed ID: 24161834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonists.
    Stocking EM; Aluisio L; Atack JR; Bonaventure P; Carruthers NI; Dugovic C; Everson A; Fraser I; Jiang X; Leung P; Lord B; Ly KS; Morton KL; Nepomuceno D; Shah CR; Shelton J; Soyode-Johnson A; Letavic MA
    Bioorg Med Chem Lett; 2010 May; 20(9):2755-60. PubMed ID: 20382018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and three-dimensional quantitative structure-activity relationship analysis of H3 receptor antagonists containing a neutral heterocyclic polar group.
    Rivara S; Mor M; Bordi F; Silva C; Zuliani V; Vacondio F; Morini G; Plazzi PV; Carrupt PA; Testa B
    Drug Des Discov; 2003; 18(2-3):65-79. PubMed ID: 14675944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies.
    Lim HD; Istyastono EP; van de Stolpe A; Romeo G; Gobbi S; Schepers M; Lahaye R; Menge WM; Zuiderveld OP; Jongejan A; Smits RA; Bakker RA; Haaksma EE; Leurs R; de Esch IJ
    Bioorg Med Chem; 2009 Jun; 17(11):3987-94. PubMed ID: 19414267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amine-constrained pyridazinone histamine H₃ receptor antagonists.
    Sundar BG; Bailey T; Bacon E; Aimone L; Huang Z; Lyons J; Raddatz R; Hudkins R
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5543-6. PubMed ID: 21824776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and SAR studies of benzimidazolone derivatives as histamine H3-receptor antagonists.
    Zeng Q; Rosenblum SB; Yang Z; Jiang Y; McCormick KD; Aslanian RG; Duguma L; Kozlowski JA; Shih NY; Hey JA; West RE; Korfmacher WA; Berlin M; Boyce CW
    Bioorg Med Chem Lett; 2013 Nov; 23(21):6001-3. PubMed ID: 24050887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
    Dvorak CA; Apodaca R; Xiao W; Jablonowski JA; Bonaventure P; Dugovic C; Shelton J; Lord B; Miller K; Dvorak LK; Lovenberg TW; Carruthers NI
    Eur J Med Chem; 2009 Oct; 44(10):4098-106. PubMed ID: 19524331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.
    Sasho S; Seishi T; Kawamura M; Hirose R; Toki S; Shimada JI
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2288-91. PubMed ID: 18353639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of 4,5-fused pyridazinones as histamine H₃ receptor antagonists.
    Tao M; Raddatz R; Aimone LD; Hudkins RL
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6126-30. PubMed ID: 21906941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-imidazole histamine H3 ligands, part IV: SAR of 1-[2-thiazol-5-yl-(2-aminoethyl)]-4-n-propylpiperazine derivatives.
    Frymarkiewicz A; Walczyński K
    Eur J Med Chem; 2009 Apr; 44(4):1674-81. PubMed ID: 18990469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel steroidal histamine H
    Ledneczki I; Tapolcsányi P; Gábor E; Éles J; Greiner I; Schmidt É; Némethy Z; Kedves RS; Balázs O; Román V; Lévay G; Mahó S
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4525-4530. PubMed ID: 28888822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzimidazole- and indole-substituted 1,3'-bipyrrolidine benzamides as histamine H3 receptor antagonists.
    Cole DC; Gross JL; Comery TA; Aschmies S; Hirst WD; Kelley C; Kim JI; Kubek K; Ning X; Platt BJ; Robichaud AJ; Solvibile WR; Stock JR; Tawa G; Williams MJ; Ellingboe JW
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1237-40. PubMed ID: 20042333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.